Follow the אורמד share price and the full directors' dealings record of the company, a listed equity based in Israel. Shares are quoted on the IL market, under the supervision of TASE (ISA). The latest transaction was filed on 20 August 2026 (Holding). Among the most active insiders: אקוומרין (ז). Every trade is free.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
189,484 shares100.0% of flowShareXTAETASE:1691:12729:1141324:2026-03-26
10 of 10 declarations
Acerca de אורמד
Oramed es una empresa centrada en el desarrollo de tratamientos innovadores para la diabetes, incluyendo soluciones orales para la administración de insulina. Cotiza en el XTAE.